Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
EpiCept receives Israeli Ministry of Health approval for Ceplene

EpiCept receives Israeli Ministry of Health approval for Ceplene

Exosomes derived from lymphoma, colorectal cancer patients circulated through Aethlon's Hemopurifier

Exosomes derived from lymphoma, colorectal cancer patients circulated through Aethlon's Hemopurifier

Possible stem cell cure for AIDS

Possible stem cell cure for AIDS

Celator granted U.S. Patent covering CombiPlex technology platform

Celator granted U.S. Patent covering CombiPlex technology platform

Researchers discover new way to prevent spread of cancer

Researchers discover new way to prevent spread of cancer

HIV patient cured!

HIV patient cured!

Cord Blood America announces acquisition of Cryo-Cell Mexico to gain profit

Cord Blood America announces acquisition of Cryo-Cell Mexico to gain profit

New findings says TRIM24 protein plays active role in breast cancer formation

New findings says TRIM24 protein plays active role in breast cancer formation

Study broadens understanding of role of IDH1 and IDH2 mutations in AML

Study broadens understanding of role of IDH1 and IDH2 mutations in AML

NCI initiates crolibulin/cisplatin combination Phase II trial in anaplastic thyroid cancer

NCI initiates crolibulin/cisplatin combination Phase II trial in anaplastic thyroid cancer

Genes predict survival time, potential new treatments for patients with non-small cell lung cancer

Genes predict survival time, potential new treatments for patients with non-small cell lung cancer

Chimerix reports positive results from CMX157 Phase 1 clinical trial for HIV

Chimerix reports positive results from CMX157 Phase 1 clinical trial for HIV

Beta-catenin protein plays a key role in development of stem cells in acute leukaemia

Beta-catenin protein plays a key role in development of stem cells in acute leukaemia

Novel labeling technique helps researchers to explore DNA chemical modification

Novel labeling technique helps researchers to explore DNA chemical modification

Lilly suspends tasisulam global Phase III study in metastatic melanoma

Lilly suspends tasisulam global Phase III study in metastatic melanoma

EMEA calls for Europe-wide ban on blood donation from ME/CFS patients

EMEA calls for Europe-wide ban on blood donation from ME/CFS patients

Stem cell therapy can reduce risk of acute leukemia in affected individuals

Stem cell therapy can reduce risk of acute leukemia in affected individuals

Clinical, preclinical results of ISF35 in CLL patients presented at ASH 2010

Clinical, preclinical results of ISF35 in CLL patients presented at ASH 2010

Clarient introduces Mammostrat test to quantify likelihood of breast cancer recurrence

Clarient introduces Mammostrat test to quantify likelihood of breast cancer recurrence

p53 activation offers a novel strategy for cancer therapy

p53 activation offers a novel strategy for cancer therapy

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.